252 related articles for article (PubMed ID: 28503836)
1. Role of anticholinergic burden in primary care patients with first cognitive complaints.
Grande G; Tramacere I; Vetrano DL; Clerici F; Pomati S; Mariani C; Filippini G;
Eur J Neurol; 2017 Jul; 24(7):950-955. PubMed ID: 28503836
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
[TBL] [Abstract][Full Text] [Related]
3. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
4. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
5. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic burden in older inpatients on psychotropic medication: do we care?
Lee MS; Kisely S; Zolotarev B; Warren A; Henderson J; George M
Australas Psychiatry; 2017 Dec; 25(6):566-570. PubMed ID: 28868891
[TBL] [Abstract][Full Text] [Related]
7. Drug Burden Index and change in cognition over time in community-dwelling older men: the CHAMP study.
Jamsen KM; Gnjidic D; Hilmer SN; Ilomäki J; Le Couteur DG; Blyth FM; Handelsman DJ; Naganathan V; Waite LM; Cumming RG; Bell JS
Ann Med; 2017 Mar; 49(2):157-164. PubMed ID: 27763767
[TBL] [Abstract][Full Text] [Related]
8. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.
Uusvaara J; Pitkala KH; Tienari PJ; Kautiainen H; Tilvis RS; Strandberg TE
J Am Geriatr Soc; 2009 Mar; 57(3):427-31. PubMed ID: 19278396
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic medications: an additional contributor to cognitive impairment in the heart failure population?
Shaukat A; Habib A; Lane KA; Shen C; Khan S; Hellman YM; Boustani M; Malik AS
Drugs Aging; 2014 Oct; 31(10):749-54. PubMed ID: 25142050
[TBL] [Abstract][Full Text] [Related]
10. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
11. Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.
Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Ilomäki J; Elliott RA
Drugs Aging; 2016 Jan; 33(1):37-44. PubMed ID: 26645294
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic Burden is Associated With Increased Mortality in Older Patients With Dependency Discharged From Hospital.
Lattanzio F; Onder G; La Fauci MM; Volpato S; Cherubini A; Fabbietti P; Ruggiero C; Garasto S; Cozza A; Crescibene L; Tarsitano A; Corsonello A
J Am Med Dir Assoc; 2018 Nov; 19(11):942-947. PubMed ID: 30049542
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anticholinergic burden of medications in older adults.
West T; Pruchnicki MC; Porter K; Emptage R
J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
[TBL] [Abstract][Full Text] [Related]
14. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
15. Can medication management review reduce anticholinergic burden (ACB) in the elderly? Encouraging results from a theoretical model.
He Z; Ball PA
Int Psychogeriatr; 2013 Sep; 25(9):1425-31. PubMed ID: 23782833
[TBL] [Abstract][Full Text] [Related]
16. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study.
Krüger C; Schäfer I; van den Bussche H; Bickel H; Fuchs A; Gensichen J; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
BMJ Open; 2021 Mar; 11(3):e044230. PubMed ID: 33757948
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales.
Novella A; Elli C; Ianes A; Pasina L
Drugs Aging; 2023 Nov; 40(11):1017-1026. PubMed ID: 37620654
[TBL] [Abstract][Full Text] [Related]
19. Potential benefits of reducing medication-related anticholinergic burden for demented older adults: a prospective cohort study.
Yeh YC; Liu CL; Peng LN; Lin MH; Chen LK
Geriatr Gerontol Int; 2013 Jul; 13(3):694-700. PubMed ID: 23216534
[TBL] [Abstract][Full Text] [Related]
20. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
